E-LIB Suche - Ergebnisse für: Schenker, N

1

The KEYNOTE-630 Trial: A Phase 3 Study of Adjuvant Pembroli..:

Schenker, M. ; Klochikhin, M. ; Kirtbaya, D....
International Journal of Radiation Oncology*Biology*Physics. 118 (2024) 5 - p. e81-e82 , 2024

Link: https://doi.org/10.1016/..

2

Pulmonary vein reconnection and repeat ablation characteris..:

Obergassel, J. ; Nies, M. ; Taraba, S....
Journal of Cardiovascular Electrophysiology. , 2024

Link: https://doi.org/10.1111/..

3

Patient-reported barriers for adherence to prophylactic eno..:

Ghazi, Fayez G. ; Schenker, Mara L. ; Smith, Randi N...
Injury. 55 (2024) 8 - p. 111650 , 2024

Link: https://doi.org/10.1016/..

4

Abstract No. 233 Communicating Learning Opportunities in In..:

Glazer, D. ; Schenker, M. ; Burk, K....
Journal of Vascular and Interventional Radiology. 34 (2023) 3 - p. S106 , 2023

Link: https://doi.org/10.1016/..

5

PB1006 Accuracy and Interrater Agreement of Death Event Adj..:

Marx, C. ; Schenker, C. ; Xu, Y....
Research and Practice in Thrombosis and Haemostasis. 7 (2023) - p. 101827 , 2023

Link: https://doi.org/10.1016/..

6

Demonstration of a Stacked CMOS Inverter at 60nm Gate Pitch..:

, In: 2023 International Electron Devices Meeting (IEDM),

Radosavljevic, Marko ; Huang, C.-Y. ; Galatage, R.... - p. 1-4 , 2023

Link: https://doi.org/10.1109/..

7

Safety and efficacy of excimer laser powered lead extractio..:

Schenker, N ; Chung, D ; Burger, H...
Europace. 25 (2023) Supplement_1 - p. , 2023

Link: https://doi.org/10.1093/..

8

41P Efficacy of first-line (1L) nivolumab (N) + ipilimumab ..:

Borghaei, H. ; Balli, D. ; Paz-Ares, L....
Journal of Thoracic Oncology. 18 (2023) 4 - p. S64-S65 , 2023

Link: https://doi.org/10.1016/..

9

P06.15.B IMMUNOTHERAPEUTIC TARGETING OF FIBROBLAST ACTIVATI..:

Tatari, N ; Mohamed Seid Hedad, H ; Zingg, A...
Neuro-Oncology. 25 (2023) Supplement_2 - p. ii49-ii49 , 2023

Link: https://doi.org/10.1093/..

10

Safety and efficacy of excimer laser powered lead extractio..:

Schenker, N ; Chung, D ; Burger, H...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207530/. , 2023

Link: http://www.ncbi.nlm.nih...

11

Reimagining the Path of an Unmatched Orthopaedic Residency ..:

Stewart A. Bryant, MD ; Achraf H. Jardaly, MD ; Brent A. Ponce, MD, FAOA...
http://journals.lww.com/jbjsoa/fulltext/10.2106/JBJS.OA.22.00044. , 2023

Link: https://doi.org/10.2106/..

12

57O Randomized double-blind phase II trial (PERLA) of dosta..:

Peters, S. ; Lim, S.M. ; Ortega Granados, A.L.O....
Immuno-Oncology and Technology. 16 (2022) - p. 100162 , 2022

Link: https://doi.org/10.1016/..

13

ProPACC: Protocol for a Trial of Integrated Specialty Palli..:

Andersen, Sarah K. ; Vincent, Grace ; Butler, Rachel A....
Journal of Pain and Symptom Management. 63 (2022) 6 - p. e601-e610 , 2022

Link: https://doi.org/10.1016/..

14

Adjuvant nivolumab versus ipilimumab (CheckMate 238 trial):..:

Larkin J ; Weber J ; Del Vecchio M...
info:eu-repo/semantics/altIdentifier/pmid/35964471. , 2022

Link: https://hdl.handle.net/1..

15

A Randomized, Phase III Trial to Evaluate Rucaparib Monothe..:

Monk, Bradley J ; Parkinson, Christine ; Lim, Myong Cheol...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746782/. , 2022

Link: http://www.ncbi.nlm.nih...